|
WDR33 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.284200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.998200E-02 |
| Normal-vs-Stage2 |
8.761400E-01 |
| Normal-vs-Stage3 |
2.476300E-02 |
| Normal-vs-Stage4 |
7.805900E-02 |
| Stage1-vs-Stage2 |
1.762620E-01 |
| Stage1-vs-Stage3 |
2.025000E-04 |
| Stage1-vs-Stage4 |
9.998700E-04 |
| Stage2-vs-Stage3 |
2.516000E-01 |
| Stage2-vs-Stage4 |
3.545400E-01 |
| Stage3-vs-Stage4 |
7.849800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.217200E-01 |
| Normal-vs-AfricanAmerican |
4.942400E-01 |
| Normal-vs-Asian |
1.262770E-01 |
| Caucasian-vs-AfricanAmerican |
4.082800E-01 |
| Caucasian-vs-Asian |
1.711010E-01 |
| AfricanAmerican-vs-Asian |
3.297000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.935800E-02 |
| Normal-vs-Female |
1.286210E-02 |
| Male-vs-Female |
1.214120E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.836000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.060800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.489000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.521400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.319000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.387600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.098400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.785800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.249200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.011400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.801100E-03 |
| Normal-vs-Grade 2 |
2.493600E-02 |
| Normal-vs-Grade 3 |
1.724840E-01 |
| Normal-vs-Grade 4 |
2.542900E-03 |
| Grade 1-vs-Grade 2 |
1.031920E-02 |
| Grade 1-vs-Grade 3 |
5.73259999999687E-05 |
| Grade 1-vs-Grade 4 |
1.35000000001106E-06 |
| Grade 2-vs-Grade 3 |
9.439400E-04 |
| Grade 2-vs-Grade 4 |
4.03469999999961E-05 |
| Grade 3-vs-Grade 4 |
5.400100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.0564000003982E-07 |
| Normal-vs-ccB subtype |
3.7081999999522E-06 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.516800E-01 |
| Normal-vs-N1 |
1.078300E-02 |
| N0-vs-N1 |
3.306000E-02 |
|
|
